Combination of HBsAg Level and Hepatitis B Viral Load at Week 12 is the Best Stopping Rule for Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

被引：0
|
作者：
Phisalprapa, Pochamana
Tanwandee, Tawesak
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S954 / S955
页数：2
相关论文
共 50 条
  • [21] Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
    Buster, Erik H. C. J.
    Hansen, Bettina E.
    Buti, Maria
    Delwaide, Jean
    Niederau, Claus
    Michielsen, Peter P.
    Flisiak, Robert
    Zondervan, Pieter E.
    Schalm, Solko W.
    Janssen, Harry L. A.
    HEPATOLOGY, 2007, 46 (02) : 388 - 394
  • [22] Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis C: a randomized, controlled study
    Bruno, R
    Sacchi, P
    Ciappina, V
    Zochetti, C
    Patruno, S
    Maiocchi, L
    Filice, G
    ANTIVIRAL THERAPY, 2004, 9 (04) : 491 - 497
  • [23] Early prediction of response to peginterferon for HBeAg-positive chronic hepatitis B using HBsAg levels at week 4 and week 8 of therapy
    Sonneveld, Milan J.
    Brouwer, Willem Pieter
    Zeuzem, Stefan
    Cakaloglu, Yilmaz
    Tabak, Fehmi
    Simon, Krzysztof
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1182A - 1182A
  • [24] HBV DNA Suppression in HBeAg-Positive Chronic Hepatitis B Patients Treated With Peginterferon or Placebo
    Hansen, Bettina E.
    Rijckborst, Vincent
    ter Borg, Martijn J.
    Janssen, Harry L. A.
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (11) : 1917 - 1923
  • [25] CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA
    Brouwer, W. P.
    Sonneveld, M. J.
    Xie, Q.
    Zhang, N.
    Zeuzem, S.
    Tabak, F.
    Zhang, Q.
    Simon, K.
    Akarca, U. S.
    Streinu-Cercel, A.
    Hansen, B.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S572 - S573
  • [26] Relapse after treatment with peginterferon a-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B
    Flink, H. J.
    Buster, E. H. C. J.
    Merican, I.
    Nevens, F.
    Kitis, G.
    Cianciara, J.
    De Vries, R. A.
    Hansen, B. E.
    Schalm, S. W.
    Janssen, H. L. A.
    GUT, 2007, 56 (10) : 1485 - 1486
  • [27] BASELINE HBsAg LEVEL PREDICT HBsAg LOSS IN CHRONIC HEPATITIS B PATIENTS TREATED WITH A COMBINATION OF PEGINTERFERON ALFA-2A AND ADEFOVIR: AN INTERIM ANALYSIS
    Takkenberg, B.
    Zaaijer, H.
    Weegink, C.
    Terpstra, V.
    Dijkgraaf, M.
    Jansen, P.
    Janssen, H.
    Beld, M.
    Reesink, H.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S8 - S8
  • [28] Significant reduction of HBsAg in the sera of HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2A alone or in combination with lamivudine
    Brunetto, Maurizia
    Bonino, Ferruccio
    Moriconi, Francesco
    Patrick, Marcellin
    George, Lau K.
    Patrizia, Farci
    Yurdaydin, Cihan
    Piratvisuth, Teerha
    Luo, Kangxian
    Wang, Yuming
    Hadziyannis, Stephanos
    Wolf, Eva
    Matei, Popescu
    HEPATOLOGY, 2006, 44 (04) : 549A - 549A
  • [29] Withdrawal flares after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg-positive chronic hepatitis B
    Buster, E. H. C. J.
    Flink, H. J.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S186 - S186
  • [30] Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy
    Park, Yongjung
    Park, Jun Yong
    Han, Kwang-Hyub
    Kim, Hyon-Suk
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (05) : 499 - 506
12345